How Should Peptic Ulcer Disease Be Managed in the Era of PPIs and H. pylori Eradication?

Peptic ulcer management requires a structured, evidence-based clinical approach. This review summarizes the key diagnostic, management, monitoring and decision points for gastroenterology and hepatology practice.

Peptic ulcer management: practical clinical approach

This page focuses on Peptic ulcer management with emphasis on decisions that change patient care, common pitfalls, and the current evidence base.

External guidance for Peptic ulcer management

• ACG Clinical Guidelines
• PubMed literature search for Peptic ulcer management

Clinical takeaway: For Peptic ulcer management, decisions should integrate current guidelines, patient-specific risk, and the evidence summarized below.

Define the cause, not just the crater

H. pylori and NSAID exposure remain the dominant causes worldwide, but aspirin, combination antithrombotic therapy, smoking, severe physiologic stress and uncommon hypersecretory or infiltrative disorders matter. A careful drug history should include over-the-counter NSAIDs and combination cold or pain remedies.

Test for H. pylori correctly

Patients with current or prior peptic ulcer disease should be tested for H. pylori unless eradication has already been documented. During acute bleeding, biopsy-based tests can be falsely negative. If suspicion remains, repeat noninvasive testing after the acute episode and after withholding medications that reduce test sensitivity.

Use PPI therapy for healing and prevention

Most uncomplicated duodenal ulcers heal with several weeks of PPI therapy; gastric ulcers generally receive a longer course. After successful H. pylori eradication and withdrawal of the injuring drug, indefinite PPI therapy is often unnecessary. Long-term PPI is appropriate when ongoing ulcer risk persists, such as continued NSAID therapy in a high-risk patient or continued antithrombotic therapy after prior ulcer bleeding.

Know when the ulcer is atypical

An ulcer that fails to heal despite appropriate therapy should trigger review of adherence, ongoing NSAID use, persistent H. pylori, malignancy, Crohn’s disease, infections in immunocompromised patients and hypersecretory states. Gastric ulcers deserve particular attention because malignancy can mimic benign ulceration.

Practical clinical algorithm

1. Confirm ulcer location, size, bleeding stigmata and whether gastric biopsies are needed.
2. Test for H. pylori and plan a reliable test of cure if positive.
3. Stop NSAIDs if possible; if they must continue, minimize dose and provide gastroprotection according to risk.
4. Treat with a PPI for an appropriate healing interval.
5. Repeat endoscopy selectively for gastric ulcers, suspicious morphology, persistent symptoms or nonhealing.
6. Investigate refractory or recurrent disease for persistent cause rather than simply escalating acid suppression.

Common mistakes to avoid

• Failing to test for H. pylori because the patient takes NSAIDs.
• Assuming a negative H. pylori test during active bleeding is definitive.
• Continuing an NSAID without reassessing indication and gastroprotection.
• Treating a gastric ulcer without adequate biopsy or follow-up when malignancy risk is present.
• Leaving patients on indefinite PPI without documenting the ongoing indication.

Trainee takeaway

Peptic ulcer disease should be treated as a causal diagnosis. Eradicate H. pylori, remove or mitigate ulcerogenic drugs, heal with PPI therapy, and investigate ulcers that do not behave as expected.

Frequently asked questions

Should every peptic ulcer patient be tested for H. pylori?

Yes, unless prior eradication has been reliably documented and there is a compelling alternative explanation.

Does every gastric ulcer need repeat endoscopy?

No. Follow-up is individualized according to appearance, biopsy adequacy, symptoms, etiology and healing risk.

Can a patient ever resume NSAIDs after ulcer bleeding?

Sometimes, if the indication is strong. Use the lowest effective risk strategy, usually with PPI gastroprotection and careful assessment of cardiovascular and GI risk.

Suggested free reading

Continue with these free books by Dr. Alan B. R. Thomson:

• Guideline-Based Management in Gastroenterology
• First Principles of Gastroenterology and Hepatology in Adults & Children – Part 1

References

1. Thomson ABR. Guideline-Based Management in Gastroenterology. CAPstone Academic Publishers; 2015.

2. Thomson ABR. First Principles of Gastroenterology and Hepatology in Adults and Children. 7th ed. CAPstone Academic Publishers; 2013.

3. Laine L, Barkun AN, Saltzman JR, Martel M, Leontiadis GI. ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding. Am J Gastroenterol. 2021;116:899-917.

4. Chey WD, Howden CW, Moss SF, et al. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. Am J Gastroenterol. 2024;119:1730-1753.

Educational content only. Clinical decisions should incorporate the individual patient, local resources, product labeling, and the most current applicable guideline or regulatory information.